RU2009112911A - METHOD FOR PREDICING DURATION OF A NON-RECIDENT PERIOD IN RADICALLY TREATED BREAST CANCER PATIENTS - Google Patents
METHOD FOR PREDICING DURATION OF A NON-RECIDENT PERIOD IN RADICALLY TREATED BREAST CANCER PATIENTSInfo
- Publication number
- RU2009112911A RU2009112911A RU2009112911/15A RU2009112911A RU2009112911A RU 2009112911 A RU2009112911 A RU 2009112911A RU 2009112911/15 A RU2009112911/15 A RU 2009112911/15A RU 2009112911 A RU2009112911 A RU 2009112911A RU 2009112911 A RU2009112911 A RU 2009112911A
- Authority
- RU
- Russia
- Prior art keywords
- duration
- relapse
- breast cancer
- period
- recident
- Prior art date
Links
Landscapes
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Способ прогнозирования продолжительности безрецидивного периода у радикально пролеченных больных раком молочной железы, включающий биохимическое исследование, отличающийся тем, что в крови определяют содержание половых гормонов - эстрадиола и прогестерона, рассчитывают коэффициент соотношения концентрации эстрадиола к концентрации прогестерона и при значениях коэффициента в границах от 10 до 221 прогнозируют продолжительность безрецидивного периода от 5 до 13 лет, а при значениях коэффициента в границах 367-1295 развитие рецидива через 28-30 месяцев после радикального лечения. A method for predicting the duration of a relapse-free period in radically treated patients with breast cancer, including a biochemical study, characterized in that the blood determines the content of sex hormones - estradiol and progesterone, calculates the ratio of the concentration of estradiol to the concentration of progesterone and with coefficient values ranging from 10 to 221 predict the duration of a relapse-free period from 5 to 13 years, and with the values of the coefficient within 367-1295 the development of relapse in 28- 30 months after radical treatment.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2009112911/15A RU2413231C2 (en) | 2009-04-06 | 2009-04-06 | Method of predicting duration of recurrence-free period in radically treated patients with mammary gland cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2009112911/15A RU2413231C2 (en) | 2009-04-06 | 2009-04-06 | Method of predicting duration of recurrence-free period in radically treated patients with mammary gland cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2009112911A true RU2009112911A (en) | 2010-10-20 |
RU2413231C2 RU2413231C2 (en) | 2011-02-27 |
Family
ID=44023498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2009112911/15A RU2413231C2 (en) | 2009-04-06 | 2009-04-06 | Method of predicting duration of recurrence-free period in radically treated patients with mammary gland cancer |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2413231C2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2463599C1 (en) * | 2011-02-22 | 2012-10-10 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации | Method for prediction of breast cancer dissemination in premenopausal females |
RU2563437C1 (en) * | 2014-06-26 | 2015-09-20 | государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет имени А.И. Евдокимова" Министерства здравоохранения Российской Федерации | Method for prediction of clinical outcome of breast cancer |
-
2009
- 2009-04-06 RU RU2009112911/15A patent/RU2413231C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2413231C2 (en) | 2011-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017502286A1 (en) | Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi) | |
NZ609493A (en) | Diagnosis and treatments relating to th2 inhibition | |
GB2467467B (en) | TAZ/WWTR1 for diagnosis and treatment of cancer | |
PH12016501728A1 (en) | Anti-angiogenesis therapy for the treatment of ovarian cancer | |
NZ609201A (en) | Means and methods for treating dlbcl | |
WO2010091049A3 (en) | Diagnosis and treatment of cancer | |
MX340724B (en) | Use of anti-vegf antibody in combination with chemotherapy for treating breast cancer. | |
EA201791876A1 (en) | MONOCLONAL PROTECTIVE ANTIBODIES AND THEIR APPLICATION | |
UA124238U (en) | METHOD OF TREATMENT OF BREAST CANCER | |
BRPI0418745A (en) | cell line antibody, pharmaceutical composition, and method of treating cancer in a patient | |
EA201001749A1 (en) | METHOD OF TREATMENT OF DIFFERENTIATED ARTHRITIS | |
CY1117234T1 (en) | METHOD OF DETERMINING PATIENTS 'SENSITIVITY IN TREATMENT OF HELP | |
WO2009091230A3 (en) | Protein marker for breast-cancer monitoring, diagnosis and screening, and a breast-cancer monitoring, diagnosis and screening method using the same | |
RU2009112911A (en) | METHOD FOR PREDICING DURATION OF A NON-RECIDENT PERIOD IN RADICALLY TREATED BREAST CANCER PATIENTS | |
MX336476B (en) | Anti-angiogenesis therapy for the treatment of previously treated breast cancer. | |
WO2011091154A3 (en) | Use of human erythrocytes for prevention and treatment of cancer dissemination and growth | |
WO2012138691A3 (en) | Diagnosis and treatment of taxane-resistant cancers | |
RU2003124101A (en) | BREAST CANCER FORECAST PREDICTION METHOD | |
RU2008152470A (en) | METHOD FOR PREDICTING THE EFFECTIVENESS OF CHEMI-RADIATION THERAPY IN PATIENTS WITH DISSEMINATED MELANOMA SKIN | |
RU2008141837A (en) | METHOD FOR PREDICTING THE COURSE OF DISEASE IN UTERINE BODY CANCER PATIENTS | |
RU2010107100A (en) | METHOD FOR PREDICTING SURVIVAL OF PATIENTS WITH MALIGNANT GLIOMAS | |
RU2009128385A (en) | METHOD FOR PREDICING DURATION OF A NON-RECIDENT PERIOD IN RECT GUT CANCER PATIENTS | |
RU2009114010A (en) | METHOD FOR INTEGRATED TREATMENT OF BREAST DYSHORMONAL HYPROPLASIES | |
RU2011126391A (en) | METHOD FOR PREDICTING THE ORIGIN OF Cervical Cancer Relapses | |
WO2010124218A3 (en) | Genetic variants in il-6, p53, mmp-9 and cxcr predict clinical outcome in patients with cancer treated with anti-vegf therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20110407 |